A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion
Related Experiment Video
Updated: Oct 26, 2026

Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection
Published on: September 14, 2019
D A Barnes1, A Bonnin, J X Huang
1Department of Medicine, University of California-San Francisco General Hospital, 94110, USA.
Abstract:
Cryptosporidium parvum is a protozoan parasite which produces self-limited disease in immunocompetent hosts and devastating, persistent diarrhea in immunocompromised individuals. There is no effective treatment for cryptosporidiosis and little is known about the basic biology of the organism. Cloning and sequence analysis of the gene encoding GP900, a previously identified > 900 kDa glycoprotein, predicts a mucin-like glycoprotein composed of distal cysteine-rich domains separated by polythreonine domains and a large membrane proximal N-glycosylated core region. A trinucleotide repeat composed predominantly of the triplet ACA encodes the threonine domains. GP900 is stored in micronemes prior to appearance on the surface of invasive forms. The concentration of native GP900 which inhibits 50% (IC50) of invasion in vitro is low picomolar; the IC50 for a recombinant cysteine rich-domain is low nanomolar. These observations indicate that GP900 is a parasite ligand for a host receptor involved in attachment/invasion and suggest that immunotherapy or chemotherapy directed against GP900 may be feasible.
Insights
Cryptosporidium parvum uses the GP900 glycoprotein to invade host cells. Targeting GP900 may offer new treatments for cryptosporidiosis, a disease lacking effective therapies.
Area of Science:
- Parasitology
- Molecular Biology
- Immunology
Background:
- Cryptosporidium parvum causes severe diarrhea, especially in immunocompromised individuals.
- No effective treatments currently exist for cryptosporidiosis.
- The basic biology of C. parvum remains poorly understood.
Purpose of the Study:
- To characterize the GP900 glycoprotein of Cryptosporidium parvum.
- To investigate the role of GP900 in parasite invasion.
- To explore GP900 as a potential therapeutic target.
Main Methods:
- Cloning and sequence analysis of the GP900 gene.
- Protein structure prediction and domain analysis.
- In vitro invasion inhibition assays using native and recombinant GP900.
Main Results:
- GP900 is a large, mucin-like glycoprotein with cysteine-rich and polythreonine domains.
- The polythreonine domains are encoded by ACA trinucleotide repeats.
- GP900 is stored in micronemes and present on invasive parasite forms.
- GP900 effectively inhibits parasite invasion in vitro, with low picomolar and nanomolar IC50 values for native and recombinant forms, respectively.
Conclusions:
- GP900 functions as a parasite ligand mediating host cell attachment and invasion.
- GP900 represents a promising target for developing novel immunotherapies or chemotherapies against cryptosporidiosis.
More Related Videos
07:00Preparing Lamellae from Vitreous Biological Samples Using a Dual-Beam Scanning Electron Microscope for Cryo-Electron Tomography
Published on: August 5, 2021
07:20Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium
Published on: April 9, 2019
Related Concept Videos
Cancer Cell Migration through Invadopodia
Colonisation of Pathogens
Fungal Phylum Microsporidia
Giardiasis
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Cryptococcal Meningitis